Assessment of lipid abnormalities after initiation of a JAK inhibitor in rheumatoid arthritis in clinical practice.

Abdellaoui S, Tabaa OA, Hecquet S, Thomas M, Combier A, Carvès S, Fogel O, Avouac J

Open source

DOI
10.1016/j.jbspin.2026.106139
Published
2026 Sep 18
Container
Joint bone spine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jbspin.2026.106139,
  title = {Assessment of lipid abnormalities after initiation of a JAK inhibitor in rheumatoid arthritis in clinical practice.},
  author = {Abdellaoui S and Tabaa OA and Hecquet S and Thomas M and Combier A and Carvès S and Fogel O and Avouac J},
  year = {2026},
  journal = {Joint bone spine},
  doi = {10.1016/j.jbspin.2026.106139},
  url = {https://doi.org/10.1016/j.jbspin.2026.106139}
}

RIS

TY  - JOUR
TI  - Assessment of lipid abnormalities after initiation of a JAK inhibitor in rheumatoid arthritis in clinical practice.
AU  - Abdellaoui S
AU  - Tabaa OA
AU  - Hecquet S
AU  - Thomas M
AU  - Combier A
AU  - Carvès S
AU  - Fogel O
AU  - Avouac J
PY  - 2026
JO  - Joint bone spine
DO  - 10.1016/j.jbspin.2026.106139
UR  - https://doi.org/10.1016/j.jbspin.2026.106139
ER  - 

APA

S, A., OA, T., S, H., M, T., A, C., S, C., O, F., & J, A. (2026). Assessment of lipid abnormalities after initiation of a JAK inhibitor in rheumatoid arthritis in clinical practice.. Joint bone spine. https://doi.org/10.1016/j.jbspin.2026.106139

Source records